Immune Response and Modeled Duration of Protection Following a Single 60 μg Hepatitis B Vaccine Booster in Susceptible Chinese University Students
Vaccines · 14.04.2026 · 14 (4) · 345
DOI: 10.3390/vaccines14040345 ↗Kurz gefasst
Fachartikel in der Zeitschrift Vaccines, online erschienen am 14.04.2026. Verfasst von Xianwei Luo und 15 weiteren Autor:innen. Beteiligte Einrichtung: Anhui Provincial Center for Disease Control and Prevention, Hefei 230601, China. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Foundation for Hepatitis Prevention and Control.
Abstract (Originalsprache)
Background
Since China incorporated the hepatitis B vaccine into its Expanded Program on Immunization (EPI) in 2002, the first cohort of infants to receive the full vaccination series has now reached college age. As vaccine-induced antibodies gradually wane, this cohort faces a higher risk of infection. Therefore, we assessed their current seroprotection status and evaluated the immunogenicity and short-term antibody kinetics of a single 60 μg booster dose in susceptible individuals, while also constructing a model of expected duration of protection.
Methods
In a multicenter study across three Anhui universities, 2988 students were screened for HBV markers. Among them, 160 who tested negative for all five markers received a single 60 μg booster. Antibody titers were monitored for 1–5 months.
Results
Serological screening showed 0.33% HBsAg positivity, 36.28% anti-HBs positivity, and 63.02% negativity for all markers, indicating high susceptibility. After the booster, seroprotection rate (SPR) remained >85% throughout follow-up, and anti-HBs geometric mean concentration (GMC) peaked at 1–2 months. Stratified analysis based on immune response status revealed that the proportion of high responders (≥100 mIU/mL) peaked early and then gradually declined, whereas the proportion of low responders (10–99.99 mIU/mL) increased over the follow-up period. A linear mixed-effects model predicted that protective levels (anti-HBs ≥10 mIU/mL) would persist for an average of 32.8 months.
Conclusions
A substantial proportion of university students lack protective immunity against hepatitis B. A single 60 μg booster rapidly and effectively induced protection, demonstrating strong immunogenicity. These findings support implementing efficient booster strategies in university settings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Anhui Provincial Center for Disease Control and Prevention, Hefei 230601, China.
- School of Public Health, Bengbu Medical University, Bengbu 233030, China.
- Chuzhou Center for Disease Control and Prevention, Chuzhou 239000, China.
- Fuyang Center for Disease Control and Prevention, Fuyang 236000, China.
- Xuancheng Center for Disease Control and Prevention, Xuancheng 242000, China.
ORCID-Profile: Jihai Tang
Förderung
- Chinese Foundation for Hepatitis Prevention and Control
Zitieren
APA
Luo, X., Zhou, W., Zhou, S., Song, F., Geng, S., Xu, H., Cheng, Y., Ren, M., Dong, Y., Lin, L., Mao, L., Wang, B., Chai, Y., Miao, P., Ma, S., & Tang, J. (2026). Immune Response and Modeled Duration of Protection Following a Single 60 μg Hepatitis B Vaccine Booster in Susceptible Chinese University Students. Vaccines, 14(4), 345. https://doi.org/10.3390/vaccines14040345
Vancouver
Luo X, Zhou W, Zhou S, Song F, Geng S, Xu H, et al. Immune Response and Modeled Duration of Protection Following a Single 60 μg Hepatitis B Vaccine Booster in Susceptible Chinese University Students. Vaccines. 2026;14(4):345. doi:10.3390/vaccines14040345
BibTeX
@article{Luo2026,
author = {Luo, Xianwei and Zhou, Wenxiang and Zhou, Shujie and Song, Feiyang and Geng, Shouyan and Xu, Haiyang and Cheng, Yuhui and Ren, Mingxue and Dong, Yan and Lin, Ling and Mao, Leijing and Wang, Binbing and Chai, Yu and Miao, Pengcheng and Ma, Shaodi and Tang, Jihai},
title = {Immune Response and Modeled Duration of Protection Following a Single 60 μg Hepatitis B Vaccine Booster in Susceptible Chinese University Students},
journal = {Vaccines},
year = {2026},
volume = {14},
number = {4},
pages = {345},
doi = {10.3390/vaccines14040345}
}
EUVIMED